Dental Care Clinics in Laplace, LA Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Robert David Ory, Jr. And Benjamin Montegat Ory Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 430 W. 5th St., Laplace, LA 70068 Phone: 985-652-9616 Fax: 985-652-9649 |
Louisiana Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 393 Belle Terre Blvd., Laplace, LA 70068 Phone: 985-893-2240 |
News Archive
Gastroenterologists provide five facts to reduce colon cancer risk
The number two cancer killer in the U.S. is often preventable and highly curable. "It's important for people to understand that, with proper screening, colon cancer can not only be detected early, but often can be prevented from developing," says Dr. Felice Schnoll-Sussman, a gastroenterologist and acting director of The Jay Monahan Center for Gastrointestinal Health at NewYork-Presbyterian/Weill Cornell Medical Center.
China begins slaughter of birds in Shanghai market after 6th death from H7N9 announced; U.S., global experts begin vaccine research
"China announced a sixth death from a new bird flu strain Friday, while authorities in Shanghai halted the sale of live fowl and slaughtered all poultry at a market where the virus was detected in pigeons being sold for meat," the Associated Press reports (Wong, 4/5).
2010 European LDN Conference: LDN can be used as effective treatment for people with MS
People with MS (Multiple Sclerosis) and others suffering with a range of often debilitating inflammatory conditions such as Chronic Fatigue Syndrome and Fibromyalgia, will take heart from advances in treatment for their conditions, and will follow events at The 2nd European LDN Conference with interest.
Cyclophosphamide drug can eliminate life-threatening immune response after bone marrow transplants
Johns Hopkins and other cancer researchers report that a very short course of a chemotherapy drug, called cyclophosphamide, not only can prevent a life-threatening immune response in some bone marrow transplant recipients, but also can eliminate such patients' need for the usual six months of immune suppression medicines commonly prescribed to prevent severe forms of this immune response.
Brookhaven's D-peptides halt HIV entry into cells
Based in part on protein structures determined at the National Synchrotron Light Source (NSLS) at the U.S. Department of Energy's Brookhaven National Laboratory, scientists at the University of Utah have developed new peptides that appear to be significantly more effective at blocking HIV's entry into cells than other drugs in their class.
› Verified 6 days ago